Current Issue

Feburary 2022

Pediatric Rheumatology Comes of Age: Part II
Yukiko Kimura, Laura E. Schanberg, Editor

The twenty-first century has been a time of enormous growth for pediatric rheumatology worldwide, spurred by the growing availability of multiple effective treatments and recognition that collaborative research is necessary to study successfully even the most common of pediatric rheumatic diseases. In North America, the incorporation and maturation of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) coincide with critical progress in approaches to treatment, disease pathogenesis, and ever-expanding medication options. As treatment options expand, our understanding of autoimmunity and the recognition of the inflammatory underpinnings of disease have grown, resulting in a broadening of the definition of pediatric rheumatic diseases to include new conditions, such as autoimmune brain disease, autoinflammatory diseases, and COVID-19–related multisystem inflammatory syndrome in children (MIS-C). In addition to CARRA, the Pediatric Rheumatology Collaborative Study Group, Pediatric Rheumatology Care and Outcomes Improvement Network, Understanding Childhood Arthritis Network, the Paediatric Rheumatology European Society, and Paediatric Rheumatology International Trials Organisation have all greatly contributed to the growth of knowledge and understanding of pediatric rheumatic diseases over the last 20 years.

Articles in Press

There are no Articles in Press at this time

Most Read


The Clinics Journals

Discover everything the Clinics journals have to offer.

About the Journal

Rheumatic Disease Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue (February, May, August, and November) focuses on a single topic in rheumatology and is presented under the direction of an experienced editor. Topics include osteoarthritis, rheumatoid arthritis, crystal diseases, MSK exam, disorders of the bone, immunodeficiency states, lupus, neuromuscular disease, pain disorders, scleroderma, vasculitis, pediatrics, therapeutics, treatment guidelines, and treatment modalities.